The severe damage caused by a tornado to one of the largest facilities making sterile injectables in the US has raised fears it could exacerbate shortages of some medicine
It looks like Astellas has been unsuccessful in its attempt to block Pfizer's generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexis
Astellas has won a reprieve in its attempt to stop Pfizer's generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a
Hospira has proven that biosimilar companies can make mistakes every bit as foolish as companies with originator products, after having arranged a lavish foreign trip for NHS pharmacists.
A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-ba
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho